Your browser doesn't support javascript.
loading
End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell acute lymphoblastic leukemia.
Parekh, Chintan; Gaynon, Paul S; Abdel-Azim, Hisham.
Affiliation
  • Parekh C; Children's Center for Cancer and Blood Disease, Children's Hospital Los Angeles, Los Angeles, California.
  • Gaynon PS; Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Abdel-Azim H; Children's Center for Cancer and Blood Disease, Children's Hospital Los Angeles, Los Angeles, California.
Pediatr Blood Cancer ; 62(11): 2040-3, 2015 Nov.
Article in En | MEDLINE | ID: mdl-25976383
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Remission Induction / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Etiology_studies / Risk_factors_studies Limits: Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Remission Induction / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Type of study: Etiology_studies / Risk_factors_studies Limits: Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2015 Type: Article